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The purpose of this current study was to evaluate whether improvement of mitochondrial
dysfunction was involved in the therapeutic effect of sevoflurane post-conditioning in
global cerebral ischemia after cardiac arrest (CA) via the PI3K/Akt pathway. In the
first experiment, animals were randomly divided into three groups: a sham group,
a CA group, a CA+sevoflurane post-conditioning group (CA+SE). Sevoflurane post-
conditioning was achieved by administration of 2.5% sevoflurane for 30 min after
resuscitation. Sevoflurane post-conditioning has a significant neuroprotective effect by
increasing survival rates and reducing neuronal apoptosis. Additionally, the gene and
protein expression of PGC-1α, NRF-1, and TFAM, the master regulators of mitochondrial
biogenesis, were up-regulated in the CA+SE group, when compared to the CA group.
Similarly, in contrast to the CA group, mitochondria-specific antioxidant enzymes,
including heat-shock protein 60 (HSP60), peroxiredoxin 3 (Prx3), and thioredoxin 2
(Trx2) were also increased in the CA+SE group. Finally, administration of sevoflurane
ameliorated mitochondrial reactive oxygen species (ROS) formation and maintained
mitochondrial integrity. In the second experiment, we investigated the relationship
between the PI3K/Akt pathway and mitochondrial biogenesis and mitochondria-
specific antioxidant enzymes in sevoflurane-induced neuroprotection. The selective
PI3K inhibitor wortmannin not only eliminated the beneficial biochemical processes
of sevoflurane by reducing the level of mitochondrial biogenesis-related proteins and
aggravating mitochondrial integrity, but also reversed the elevation of mitochondria-
specific antioxidant enzymes induced by sevoflurane. Therefore, our data suggested
that sevoflurane post-conditioning provides neuroprotection via improving mitochondrial
biogenesis and integrity, as well as increasing mitochondria-specific antioxidant enzymes
by a mechanism involving the PI3K/Akt pathway.
Keywords: sevoflurane, post-conditioning, PI3K/Akt, global cerebral ischemic injury, mitochondrial biogenesis
Wang et al. Sevoflurane Post-conditioning Induced Neuroprotection
INTRODUCTION
A brief period of global brain ischemia, such as that induced
by cardiac arrest (CA) or cardiopulmonary bypass surgery can
occur under various perioperative circumstances and result in
long-term neurological disability or death. Compelling evidences
have shown that reperfusion after global cerebral ischemia causes
severe damage to mitochondria (Zhou et al., 2011; Jiang et al.,
2014; Park et al., 2015). It’s well-known that mitochondria
play an essential and pivotal role in cellular bioenergetics
by regulating energy metabolism, generating reactive oxygen
species (ROS), and mediating apoptosis in response to cerebral
ischemia (Guo et al., 2016). Previous studies have suggested
that mitochondrial dysfunction aggravates neuronal injury after
ischemic reperfusion because nerve cells are greatly dependent
on mitochondria to support their high energy demand (Rau
et al., 2012; Miao et al., 2016) Thus, the causes of mitochondrial
dysfunction in ischemic reperfusion are the objects of intense
investigations, in view of possible therapeutic applications.
Several lines of evidence have pointed to alteredmitochondrial
biogenesis as one of the causal mechanisms of mitochondrial
dysfunction, which occurred during the reperfusion period
following cerebral ischemia in animals (Wang et al., 2014;
Xie et al., 2014). Mitochondrial biogenesis is regulated by a
network of signaling factors, including three most important
ones as follows. Firstly, peroxisome proliferator-activated
receptor γ coactivator-1α (PGC-1α) is a major regulator
involved in mitochondrial biogenesis and plays an important
role in oxidative metabolism in the brain (Kleiner et al., 2009).
Secondly, nuclear respiratory factor 1 (NRF-1), the first isolated
mammalian transcription factor common to the expression
of nuclear respiratory genes, functions as a positive regulator
of transcription (Scarpulla, 2002). Lastly, mitochondrial
transcriptional factor A (TFAM) is involved in mitochondrial
DNA (mtDNA) maintenance and drives the transcription and
replication of mtDNA (Escrivá et al., 1999; Scarpulla, 2002).
Sevoflurane, a novel volatile anesthetic with minimal
pungency, low solubility and less toxicity, is used widely
in anesthetic practice. Recently, we have demonstrated that
sevoflurane preconditioning and post-conditioning could
alleviate ischemic reperfusion injury in the brain (Ye et al.,
2012a,b,c, 2015). However, the mechanism of sevoflurane’s
protective effect on cerebral ischemia in the context of
mitochondrial dysfunction has not been well-investigated.
Additionally, recent studies demonstrated that some specific
antioxidant enzymes are located in mitochondria, such as
heat shock protein 60 (HSP60), peroxiredoxin 3 (Prx3), and
thioredoxin 2 (Trx2), which protect mitochondria against
ROS-induced damage by catalyzing the reduction of H2O2
into water (Hwang et al., 2010; Lee et al., 2015). So far, it has
not been well-established in a global cerebral ischemic model
whether these mitochondria-specific antioxidant enzymes in the
hippocampus mediates the neuroprotective effect of sevoflurane.
Mitochondrial dysfunction was characterized by loss of
mitochondrial membrane potential (MMP) and opening of
mitochondrial permeability transition pore (MPTP), and
initiated mitochondria-mediated apoptosis, a pathological
response to hypoxia-ischemia injury (Gong et al., 2013). Hence,
it will be interesting to further explore whether sevoflurane
post-conditioning plays a role in maintaining mitochondrial
structural integrity after global cerebral ischemia.
Previous studies have indicated that phosphatidylinositol-
3-kinase (PI3K)/Akt pathway, an anti-apoptotic pro-survival
kinase signaling cascade, plays a pivotal role in anesthetic
post-conditioning. Recently, we have demonstrated that the
neuroprotective effect from sevoflurane post-conditioning may
be due to the activation of the PI3K/Akt survival pathway and
the inhibition of neuronal apoptosis (Ye et al., 2015). Whether
the PI3K/Akt pathway is also essential for mitochondrial
biogenesis-mediated sevoflurane post-conditioning has yet to be
investigated.
In the present study, therefore, we used a CA-induced
global cerebral ischemic in vivo model to investigate whether
sevoflurane post-conditioning is capable of promoting
neuronal survival after global cerebral ischemia via preserving
mitochondrial biogenesis and integrity and increasing expression
of mitochondria-specific antioxidant enzymes, and whether this




Adult male Sprague-Dawley (SD) rats, weighing 300–400 g, were
used in the experiments. The rats were kept at room temperature
with a 12 h light/dark cycle following surgery. They had access
to food and water ad libitum and were food-deprived for 12 h
before surgery. The study was approved by the ethics committee
of Central South University and conducted according to the
National Institutes of Health (NIH) Guide. All efforts were made
to minimize animal suffering during the experiments.
Establishment of a CA Animal Model
A rat model of CA was established by the delivery of alternating
current between the esophagus and the chest wall to induce
ventricular fibrillation based on our previous study (Huang
et al., 2013). All animals were fasted but given free access
to water on the night prior to the experiment. All animals
were anesthetized by single dose intraperitoneal injection of
chloral hydrate (350 mg/kg, IP). After trachea intubation, all
animals were mechanically ventilated (Harvard Model 683 Small
Animal Ventilator, Harvard Apparatus, Massachusetts) with a
mixture of N2O and O2 (70:30%) at a tidal volume of 8
ml/kg, a breathing rate of ∼60 min−1, adapted to maintain
normocapnia (assessed by blood gas analyses) and no positive
end-expiratory pressure. Polyethylene catheters were inserted
into the left femoral artery and vein to monitor arterial blood
pressure or inject drugs. An electrocardiogram was recorded
by three subcutaneous needle electrodes, and a tympanic
membrane temperature (Tty) probe was used to maintain Tty
at 37.5 ± 0.2◦C by using a lamp and heating pad. A BL-420s
multichannel physiological signal recording system (Chengdu
Taimeng Science and Technology Co., Ltd., Chengdu, China)
was used to record the electrocardiogram, rectal temperature
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 November 2016 | Volume 10 | Article 271
Wang et al. Sevoflurane Post-conditioning Induced Neuroprotection
and arterial blood pressure. Ventricular fibrillation was initiated
using alternating current (12 V, 50 Hz) via an esophageal
electrode and ventilation was stopped. CA was identified using
the following criteria: (1) the systolic arterial pressure after
electrical stimulation gradually fell to below 25 mmHg; and (2)
pulsations in the arterial pressure waveform disappeared. After
reaching the criteria for CA, electrical stimulation was performed
for 2 min followed by 5 min of observation without treatment.
After 7 min of CA, cardiopulmonary resuscitation (CPR) was
started: 60 breaths/min (100% oxygen), external manual chest
compression at a rate of 200 min−1, duty cycle 50%, and
compression depth of 25% of the anterior-posterior diameter of
the chest. After 2 min of CPR without restoration of spontaneous
circulation (ROSC), a defibrillation attempt was performed with
one biphasic shock of 1 Joule (M-Series, Zoll Corporation,
Germany). CPR was continued and adrenaline administered
(epinephrine, 20 µg/kg), if ROSC could not be achieved 30 s
after the first defibrillation attempt. Defibrillation procedures
were repeated after 30 s each. In case of 6 min of unsuccessful
CPR, resuscitation was stopped and the animal was declared
dead. ROSC was defined as maintenance of an unassisted
MAP beyond values of 50 mmHg for at least 10 consecutive
minutes. No further defibrillation or cardioversions, vasopressors
or antiarrhythmic drugs were allowed after ROSC was achieved
once. Breathing rate was adjusted to reach normocapnia 20
min after ROSC and maintain it until sufficient spontaneous
ventilation and extubation. Application of sodium bicarbonate
(8.4%) was titrated according to the blood gas analyses aiming
at a base excess of 0 to –5 mmol/L, 20 min after ROSC.
Animals without ROSC following standard cardiopulmonary
resuscitation (CPR) for 15 min were defined as resuscitation
failures.
Experimental Design
The rats were randomly assigned into three groups for the
first experiment: a sham group (no CA), a CA group, and a
CA+sevoflurane post-conditioning group (CA+SE). The core
temperature of the rats was continuously measured with a rectal
temperature probe, which was maintained at 37± 0.5◦C using an
infrared thermolamp until awake or 4 h after ROSC. Arterial and
venous catheterization, anesthesia and endotracheal intubation
were performed in the sham group. An esophageal electrode was
implanted in the sham group with a length of 10 cm from the
incisor, and then electrical stimulation using the same parameters
was performed for 90 s to induce generalized twitching but not
CA. In the CA groups, ventricular fibrillation was induced for 7
min and then standard CPR was performed. Sevoflurane post-
conditioning group (CA+SE): rats were subjected to ischemia
induced by cardiac arrest plus sevoflurane post-conditioning.
Sevoflurane, which was delivered to gas admixture (oxygen) at a
concentration of 2.5% via acalibrated vaporizer (Sevorane Vapor
15.3, Abbott), was administered after 60 min stable phase via
an endotracheal tube for 30 min and the inhalational oxygen
and sevoflurane concentrations were maintained and monitored
constantly by a gas analyzer (Datex-Oheda, Helsinki, Finland).
In the second set of experiments, rats were randomly assigned
into five separate experimental groups. In the sham (S) and CA
groups, rats were subjected to the same procedures as those in
the first part of this experiment. The rats in the wortmannin
group (CA+W) were injected intravenously with wortmannin
(Sigma, St. Louis, MO, USA) at 0.6 mg/kg 45 min after successful
ROSC and the rest of the procedure was same as that described in
the CA group. Wortmannin was dissolved in normal saline at a
concentration of 5 ml/kg. In the sevoflurane post-conditioning
group (CA+SE+SAL), equal volume saline was administered
in the same manner 15 min before sevoflurane exposure and
the rest of protocol was same as that described in CA+SE
group. Sevoflurane plus wortmannin group (CA+SE+W) was
administered intravenously with wortmannin 0.6 mg/kg 15 min
before sevoflurane exposure via the right femoral vein and the
rest of protocol was the same as that described in the SE group
above (Figure 1).
Nissl Staining and TUNEL Assay
Paraffin-embedded brain tissues were cut into 5 µm sections,
and Nissl staining and TUNEL assays (Beyotime Institute of
Biotechnology, Nantong, China) were performed for in situ
detection of apoptosis. Five fields of vision (magnification of
400×) in the hippocampal CA1 area were randomly sampled
from each brain tissue sample, and Nissl-stained neuronal
cells were counted. For TUNEL assay, One Step TUNEL
Apoptosis Assay Kit (Beyotime, China) was used according
the manufacturer’s instruction. For each section, the density of
TUNEL-positive cells was expressed as the number of apoptotic
cells per mm2. For each animal, the mean density of apoptotic
cells was calculated in each region of the brain based on up to
5 sections.
RNA Isolation and cDNA Synthesis and
Quantitative Real-Time PCR
Total RNA was isolated from frozen hippocampal samples
using RNeasy Mini kit (Qiagen) according to the manufacturer’s
instructions. FivemicrogramRNAwas used to synthesize the first
strand of cDNA using random hexamer primers and SuperScript
First-strand synthesis system for RT-PCR (Invitrogen). PCR
was performed using SYBR Green PCR Master Mix (Applied
Biosystems). Fluorescence was quantified using SDS v1.2x system
software (Applied Biosystems). The forward and reverse primers
used were: TFAM, GAAAGCACAAATCAAGAGGAG, CTGC
TTTTCATCATGAGACAG; NRF-1, TTACTCTGCTGTGGCT
GATGG, CCTCTGATGCTTGCGTCGTCT; PGC-1α, GTGCAG
CCAAGACTCTGTATGG, GTCCAGGTCATTCACATCAAGT
TC; and GADPH, GGGTCAGAAGGATTCCTATG, GGTCTC
AAACATGATCTGGG.
Mitochondrial DNA Quantification
The mitochondrial DNA (mtDNA) copy number was measured
using real-time PCR as described in a previous study (Edwards
et al., 2010). The animals were decapitated at 4, 12, 24, and
72 h after reperfusion and the hippocampal tissue was isolated
rapidly. Total DNA was extracted from the brain tissue using
QIAamp DNA extraction kit (Qiagen, Shanghai, China). In
total, 10 ng of genomic DNA was used for amplifying mtDNA
and nuclear DNA markers. The mtDNA was amplified using
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FIGURE 1 | Diagram of the experimental procedures. IP, intraperitoneal injection; VF, ventricular fibrillation; CA, cardiac arrest; CRP, cardiopulmonary
resuscitation; ROSC, restoration of spontaneous circulation; S, sham group; CA, cardiac arrest group; SE, Sevoflurane; W, Wortmannin.
primers specific for the mitochondrial cytochrome b (Cyt B)
gene, and the mitochondrial DNA copy number was normalized
to nuclear DNA copy number by amplifying β-actin nuclear gene.
The oligonucleotides (probes) for TaqMan PCR were labeled
with fluorescent reporter dye FAM (6-carboxyfluorescein) at
the 5′ end and fluorescent BHQ-1 dye at the 3′ end. Real-
time PCR amplification was performed using a LightCyclerTM
480 II Probes Master kit (Roche Applied Science, Mannheim,
Germany). The fluorescence threshold (Ct) value was calculated
using LightCyclerTM 480 II Probes system software (Roche
Applied Science, Germany), and the 2−11Ct method was used to
calculate the relative levels of expression (Livak and Schmittgen,
2001). The primer and probe sequences are listed in Table 1.
Isolation of Mitochondrial Fraction
The mitochondrial fraction of the harvested brain tissues
(hippocampus) was prepared as previously described (Liao et al.,
2014). The cytosolic andmitochondrial fractions of the harvested
TABLE 1 | Mitochondrial DNA sequences.
Gene Primer sequence (5′–3′)
CytB Forward primer: TCCTGCATACTTCAAAACAACG
Reverse primer: AACATICCGCCCAATCACCCAAA
Probe: AACATTCCGCCCAATCACCCAAA
ß-actin Forward primer: CTATGTTGCCCTAGACTTCGAGC
Reverse primer: TTGCOGATAGTGATGACCTGAC
Probe: CACTGCCGCATCCTCTTCCTCCC
brain tissues were prepared. Each brain tissue sample was
homogenized in ice-cold lysis buffer [200 mM mannitol, 80 mM
HEPES-KOH (pH 7.4), and protease inhibitor cocktail] by 35
strokes of gentle pounding in a glass tissue grinder. Homogenates
were centrifuged at 750 × g for 10 min at 4◦C. After removing
a portion of the supernatant, the remaining supernatant was
centrifuged at 8000 × g for 20 min at 4◦C. The mitochondrial
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fraction was obtained after washing the resultant pellets three
times and resuspending the pellets in lysis buffer.
Western Blot
Hippocampal tissues were harvested from each of the two
hemispheres at 24 and 72 h after reperfusion. Hippocampal
protein extracts and Western blot analysis were performed
as previously described (Kocki et al., 2015) using 20–50
µg of protein extract per lane. Equal amounts of protein
were loaded in each well and subjected to 10% sodium
dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Separated proteins were then transferred from the gel to
polyvinylidene fluoride (PVDF; Millipore, Bedford, MA, USA)
membranes and blocked in 5% non-fat dry milk prepared in 1×
TBST. The membranes were incubated with primary antibodies
overnight at 4◦C. The membranes were incubated with primary
antibodies for caspase-3 and -9; PGC-1α, NRF-1, and HSP
60 (all from Santa Cruz Biotechnology Inc.); TFAM, p-Akt
(Ser473), Akt and GAPDH (Cell Signaling Technology, Beverly,
MA, USA); Trx-2, Prx-3, and VDAC (Abcam, Cambridge, MA,
USA). The membranes were washed with 1X TBST and the
membranes incubated with appropriate secondary antibodies for
2 h at room temperature. The blots were developed using an
ECL plus detection system (Beyotime Institute of Biotechnology)
and relative band density was measured using FluorChem FC2
System (NatureGene Corp., USA).
Measurement of Mitochondrial ROS
Formation
ROS formation was assayed using a previously described
dichlorodihydrofluorescein diacetate (DCFH-DA) assay (HaMai
et al., 2001). In brief, 10 µl of mitochondria (5–10µg) was
suspended in 170ml HEPES buffer (120mM NaCl, 2.5mM KCl,
1.2mM NaH2PO4, 0.1mM MgCl2, 5.0mM NaHCO3, 6.0mM
glucose, 1.0mM CaCl2, 10mM HEPES, pH 7.4) in 96-well-
plates; 20ml of 100mM DCFH-DA was added to each well, for
a final volume of 200ml. Fluorescence was read at an excitation
wavelength of 485 nm and an emission wavelength of 530 nm
using a fluorescent plate reader (Genios, TEC AN). Increased
fluorescence intensity was considered to be indicative of an
increase in intracellular ROS.
Measurement of MMP
Changes in MMP were monitored in the presence of the
fluorescent dye Rhodamine 123 (Rh123), as described previously
(Emaus et al., 1986) with modifications. In brief, 10 µl of
mitochondria (5–10µg) was suspended in 90 µl of assay buffer
(15 mM sucrose, 5 mM MgCl2, 5 mM sodium succinate,
5 mM K2HPO4, 20 mM HEPES, pH 7.4) in 96-well-plates
and was incubated for 30 min in the presence of 20 µl of
100 µg/mL Rh123. The change of MMP was determined by
measuring the fluorescence change in the reaction mixture
at an excitation wavelength of 485 nm and an emission
wavelength of 538 nm. The results were expressed as fluorescence
intensities.
Measurement of MPTP Opening with
Calcein AM
MPTP opening was determined using a commercially available
kit (GENMED SCIENTIFICS INC. U.S.A) according to the
manufacturer’s instructions. Isolated mitochondria were co-
loaded with 1mM calcein AM and 1mM CoCl2 at room
temperature in working solution (pH = 7.2). The working
solution consists of 10mM EGTA-CaEGTA buffer (free Ca2+
concentration 100 nM), 3mM free Mg2+, 20mM taurine,
0.5mM dithiothreitol, 20mM imidazole, 0.16M potassium 4-
morpholineethanesulfonate and 10mg/ml fatty acid-free bovine
serum albumin. MPTP opening was measured directly using
a combination of calcein AM and CoCl2. Calcein AM, which
fluoresces upon binding with Ca2+, was used to detect transient
MPTP opening in isolated mitocchondria. This was achieved by
monitoring changes in mitochondrial Ca2+ levels in the presence
of CoCl2, which quenched the cytosolic Ca
2+ signal produced by
calcein AM. The fluorescence of calcein AM was monitored at
an emission/excitation wavelength of 530/488 nm. The extent of
Ca2+-induced MPTP opening was estimated by determining the
difference in fluorescence intensity.
Statistical Analysis
All measurement data were expressed as mean ± standard
deviation (SD), and all statistical analyses were performed using
statistical software (SPSS version 13.0). Comparison of the same
parameters among groups was done using one-way analysis of
variance (ANOVA), and the difference between pairs of means
was tested post-hoc with Fisher’s Least Significant Difference
(LSD) test. The difference in survival rates among the various
groups was compared using Wilcoxon (Gehan) survival analysis.
P < 0.05 was considered statistically significant.
RESULTS
Physiological Variability during the Study
The physiological parameters (MAP, pH, and glucose) and levels
of arterial blood gas tensions including PaCO2 and PO2 were
monitored before, during, and after (1 and 3 h post-ROSC) CA
(Table 2). The baseline parameters were similar across different
animal groups with no significant difference. Additionally, there
were no significant differences in body weight, basal body
temperature, breathing frequency, and heart rate of the rats
among three groups.
Survival of Rats
Ventricular fibrillation was successfully induced in all rabbits
in the CA group and the two CA+SE groups. There were no
significant differences in the resuscitation parameters among the
groups (P > 0.05; Table 3). The 72 h survival rates in the sham
group, CA group, CA+SE 100% (6/6), 43.75% (7/16), 62.5%, and
(9/16), respectively. The survival rate of rabbits in the sham group
was significantly different from those in the 2 groups with CA. In
addition, a significant difference in the survival rate was found
between the CA+SE and the CA group (P < 0.05; Figure 2).
The number of deaths in different groups at each time point has
shown in Table 4.
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TABLE 2 | Physiological parameters.
Groups Time MAP (mmHg) pH PaCO2 (mmHg) PaO2 (mmHg) HR [bpm] Glc (mg/dl)
Sham Baseline 110±6 7.41± 0.03 41.5±4.8 141.7± 14.8 272± 13 167± 22
VF 105±3 7.43± 0.02 40.7±2.9 154.7± 17.2 0 171± 25
ROSC 1 h 102±4 7.36± 0.03 39.6±3.5 134.7± 14.9 254± 11 173± 21
ROSC 3 h 108±3 7.33± 0.03 38.2±3.1 142.7± 17.1 277± 12 169± 23
CA Baseline 107±8 7.45± 0.06 40.5±3.4 145.4± 18.2 256± 11 176± 23
VF 22±2a 6.63± 0.12a 90.7±7.8a 10.3± 4.2a 0 520± 18a
ROSC 1 h 95±4 7.43± 0.05 45.7±3.9 125.9± 12.7 283± 13 356± 25a
ROSC 3 h 98±5 7.40± 0.08 40.8±5.0 145.7± 7.3 271± 14 289± 21
CA+SE Baseline 103±4 7.38± 0.05 39.3±4.1 145.5± 11.8 261± 12 175± 23
VF 23±3a 6.83± 0.13a 95.6±7.2a 9.7± 2.3a 0 487± 23a
ROSC 1 h 98±9 7.32± 0.05 39.6±3.7 125.6± 7.9 267± 15 347± 17a
ROSC 3 h 96±4 7.36± 0.04 41.1±2.3 146.1± 8.4 259± 12 223± 19
Sham Baseline 109±6 7.38± 0.03 39.5±4.3 147.7± 15.6 257± 12 165± 19
VF 111±3 7.41± 0.02 42.7±2.7 158.1± 18.3 0 171± 21
ROSC 1 h 106±4 7.39± 0.03 41.4±4.1 140.7± 13.2 277± 17 174± 21
ROSC 3 h 112±3 7.37± 0.03 39.6±4.1 143.5± 13.5 263± 12 182± 22
CA Baseline 113±8 7.40± 0.06 43.5±3.4 147.4± 16.8 252± 11 183± 25
VF 21±2a 6.45± 0.11a 92.7±6.7a 9.3± 3.5a 0 556± 38a
ROSC 1 h 97±5 7.40± 0.05 43.7±3.2 123.2± 134 243± 9 363± 25a
ROSC 3 h 93±2 7.38± 0.08 42.3±3.4 147.7± 8.8 261± 10 232± 21
CA+SE+SAL Baseline 108±4 7.42± 0.04 41.3±4.2 143.5± 12.1 271± 15 179± 21
VF 18±2a 6.63± 0.14a 93.6±6.2a 10.7± 4.3a 0 572± 19a
ROSC 1 h 95±4 7.38± 0.04 38.6±3.2 135.6± 6.2 263± 12 341± 15a
ROSC 3 h 106±9 7.39± 0.04 42.3±3.6 143.1± 7.4 258± 10 211± 14
CA+Se+W Baseline 114±5 7.43± 0.03 41.6±4.9 151.2± 5.5 262± 11 172± 21
VF 20±2a 6.68± 0.14a 94.4±7.2a 12.3± 3.4a 0 578± 35a
ROSC 1 h 100±3 7.36± 0.03 40.5±3.1 125.7± 5.6 250± 10 349± 23a
ROSC 3 h 102±4 7.41± 0.02 38.8±5.2 143.9± 6.7 245± 9 234± 17
CA+ W Baseline 112±3 7.42± 0.03 40.7±5.8 109± 4 271± 9 169± 25
VF 21±3a 24± 3a 20±2a 19± 3a 0 568± 34a
ROSC 1 h 107±5 97± 4 95±3 97± 2 262± 10 357± 27a
ROSC 3 h 98±6 99± 5 96±4 100± 4 265± 11 217± 12
All values are the mean ± SD. Arterial blood gas tensions include PaO2, PaCO2, pH, and Glc. MAP, mean arterial pressure; PaO2, arterial oxygen pressure; PaCO2, arterial carbon
dioxide pressure; HR, heart rate; Glc, glucose. aControlled parameter.
TABLE 3 | Comparison of resuscitation parameters in the 2 groups witb CA.
Group ICAT (s) DOCPR (s) DF AF MVT (min)
CA 34.35 ± 13.16 212.64 ± 73.47 0.73 ± 0.49 4.84 ± 1.72 38.72 ± 11.08
CA+SE 37.58 ± 13.89 203.34 ± 64.85 0.75 ± 0.62 4.55 ± 1.59 33.53 ± 12.84
ROSC, restoration of spontaneous circulation; ICAT, induce CA time (s); DOCRP, duration of CRP (s); DP, defibrillation frequency; AF, administration frequency, MVf, mechanical ventilation
time (mm).
Sevoflurane Treatment Ameliorate
Neuronal Injury in the Hippocampus
Delayed neuronal death in the hippocampus was detected at
72 h after reperfusion. Compared with the sham group (100%),
the number of neurons in other two groups with CA was
significantly reduced (P < 0.01). In the CA group, the number
of neurons was significantly reduced (46.98 ± 8.36%), and
the nucleus was compressed; a Nissl body was not found in
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FIGURE 2 | Survival rates for the S, CA, and CA+SE groups. *P < 0.05
vs. CA group. S, sham group; CA, cardiac arrest group; SE, Sevoflurane.
TABLE 4 | The number of deaths in different groups at each time point.
Group/Period Number of deaths Total number of deaths
4 h 12 h 24 h 72 h
EXPERIMENT 1
S 0 0 0 0 0
CA 2 3 3 2 10
CA+SE 0 2 2 2 6
EXPERIMENT 2
S 0 0 0 0 0
CA 2 4 3 3 12
CA+SE+SAL 0 2 3 0 5
CA+SE+W 2 3 4 3 12
CA+W 1 3 4 2 10
the cytoplasm. Compared with the CA group, many neurons
with normal nucleus were found in the CA+SE group (70.62
± 6.23%) and there were many Nissl bodies observed in the
cytoplasm, suggesting that sevoflurane preserved more intact
neurons (Figures 3A,B).
TUNEL staining showed many strongly TUNEL-positive
apoptotic cells in the CA group, and a few weakly positive cells
in the CA+SE groups. However, no TUNEL-positive cells were
found in the sham group. Compared with the sham group, the
TUNEL positive cells were significantly increased in the CA and
CA+SE groups (P< 0.01). However, the TUNEL positive cells in
the CA+SE group were significantly lower than those in the CA
group (185.36± 40.63/mm2 in CA group vs. 95.69± 25.68/mm2
in CA+SE group, P < 0.05, Figures 3C,D).
Figure 3E represents the typical results of Western blot
analysis of cleaved caspase-3 and -9 at 24 and 72 h after
reperfusion, respectively. There was low expression of cleaved
caspase-3 and -9 in the sham group. The quantitative analysis
in Figure 3F indicated that there were higher cleaved caspase-3
and -9 expressions in the CA group than in the CA+SE group,
suggesting that sevoflurane post-conditioning can efficiently
attenuate neuronal apoptosis (P < 0.05).
Sevoflurane Post-conditioning Promoted
Mitochondrial Biogenesis after Ischemic
Reperfusion
Mitochondrial DNA (mtDNA) replication is necessary for
mitochondrial biogenesis and is a typical marker for this process.
Hence, we detected the relative abundance of mitochondria in
the reperfused cerebral hippocampal tissue by measuring the
mtDNA content using quantitative real-time PCR. The mtDNA
content was examined 4, 12, 24, and 72 h after reperfusion.
Compared with the sham group, the mtDNA content was
increased in the CA and CA+SE groups in a time-dependent
manner and peaked at 24 h (P < 0.05). In the CA+SE group,
the mtDNA content were 1.4-, 1.5-, 1.3- and 1.2-fold higher,
respectively, than those of the CA group at each time point
(P < 0.05, Figure 4A).
Additionally, to determine the intrinsic specificity in
mitochondrial biogenesis, we examined PGC-1α, NRF-1, and
TFAM -transcription factors that have been reported to control
mitochondrial gene expression. The mRNA expression levels
of PGC-1α, NRF-1and TFAM were examined at 4 h, 12, 24,
and 72 h after reperfusion by quantitative real-time PCR. Low
levels of PGC-1α, NRF-1, and TFAM mRNA were observed in
the hippocampus of the sham group. Compared with the sham
group, PGC-1α, NRF-1, and TFAM mRNA were significantly
induced in CA and CA+SE groups in a time-dependent manner
and peaked at 24 h (P < 0.05). However, in contrast with the
CA group, sevoflurane post-conditioning markedly increased
the expression of PGC-1α, NRF-1, and TFAM mRNA in the
hippocampus after 72 h of reperfusion (P < 0.05, Figure 4B).
To gain additional evidence for sevoflurane protective effect
on the mitochondrial biogenesis, the protein expression levels
of PGC-1α, NRF-1, and TFAM were investigated using Western
blot analysis. Protein levels of PGC-1α, NRF-1, and TFAM were
significantly increased at 24 and 72 h after reperfusion, when
compared to the sham group (P < 0.05). Compared with the
CA group, administration of sevoflurane significantly elevated
the protein expression levels of PGC-1α, NRF-1, and TFAM (P<
0.05, Figures 4C,D).
Additionally, PI3K and its downstream protein Akt
are known to play an important role in survival against
ischemia/reperfusion-induced brain damage. To investigate
whether Akt is involved in sevoflurane-induced neuroprotection,
we evaluated the expression of Akt and its activated,
phosphorylated form [p-Akt (Ser473)]. Total Akt expression was
comparable in all experimental groups. p-Akt (Ser473) expression
was significantly increased in the CA and CA+SE groups
compared with sham-operated controls (P < 0.05). However,
the expression of p-Akt (Ser473) was apparently increased by
sevoflurane post-conditioning, when compared with the CA
group (P < 0.05, Figures 4E,F).
Effect of Sevoflurane Post-conditioning on
Mitochondrial Antioxidant Protein
Expression after Reperfusion
To gain additional evidence for the neuroprotection induced
by sevoflurane post-conditioning, the expression level of several
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FIGURE 3 | Sevoflurane treament ameliorate cerebral ischemic injury in CA model. (A) Nissl staining showed the pathological changes in CA1 region;
Magnification 400×, Bar = 100 µm. (B) The percentage of intact neurons in CA1 region after 72 h reperfusion in different groups (n = 6). (C) TUNEL staining was
performed on the CA1 region. Magnification is 400×. Scale bar = 100 µm. (D) The statistical analysis of apoptotic neurons in CA1 region of different group (n = 6).
(E) Western blot analysis showed cleaved caspase-3 and -9 expression in the hippocampus of animals treated with or without sevoflurane. (F) Quantification of
cleaved caspase-3 and -9 expression at 24 and 72 h after global cerebral ischemia. Data are expressed as mean ± S.D. n = 6–8 rats for each group. ※P < 0.05 vs.
the sham group; #P < 0.05 vs. the CA group.
proteins normally enriched in mitochondria was investigated.
Heat-shock protein 60 (HSP60), an abundant protein located
primarily in mitochondria, was found to rise significantly 24 and
72 h after reperfusion in the CA+SE group, when compared
with the CA group. Similarly, mitochondria-specific antioxidant
enzymes such as peroxiredoxin 3 (Prx3) and thioredoxin 2 (Trx2)
were examined by Western blot analysis at 24 and 72 h after
reperfusion in the mitochondrial fraction. Compared with the
CA group, the sevoflurane post-conditioning group had much
higher protein expression of mitochondrial Prx3 and Trx2 at 24
and 72 h after reperfusion (Figures 5A,B).
Mitochondrial ROS (mROS) Formation and
Evaluation of Mitochondrial Integrity
To determine if the protective effect of sevoflurane post-
conditioning is due to a reduction in ROS production, mROS
production was measured by using DCFH-DA at 24 and 72
h after reperfusion. As shown in Figure 6A, ROS production
in mitochondria of hippocampal neurons in the CA group
markedly increased to 269.7% at 1 day, then gradually decreased
to 203.5% at 3 days compared to sham group. On the other hand,
sevoflurane exhibited mROS production levels of 156.8% at 1 day
and 137.3% at 3 days compared to sham group, which suggested
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FIGURE 4 | Effect of sevoflurane post-conditioning on hippocampal neuronal mitochondrial biogenesis after global cerebral ischemic injury. (A) The
relative amounts of hippocampal mtDNA were measured using quantitative real-time PCR in three groups. (B) The histogram shows the quantitative measurement of
real-time PCR products of mitochondrial biogenesis factors obtained using densitometric analysis. (C) Western blot images for PGC-1A, NRF-1, and TFAM in rats in
the presence and absence of sevoflurane; (D) Quantitative analysis of PGC-1A, NRF-1, and TFAM expression levels. (E) Western blots analysis for p-Akt in the
hippocampus of different group at 24 and 72 h after reperfusion. (F) Quantitative analysis for the level of p-Akt in thehippocampus. Data are expressed as mean ±
S.D. n = 6–8 rats for each group. ※P < 0.05 vs. the sham group; #P < 0.05 vs. the CA group.
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FIGURE 5 | Effect of sevoflurane post-conditioning on mitochondrial antioxidnt protein expression. (A) Representative Western blots showing HSP60,
Prx3, and Trx2 protein levels in rats in the presence and absence of sevoflurane; (B) Graph showing semiquantitative analysis showing the protein levels of HSP60,
Prx3, and Trx2. Data are expressed as mean ± S.D. n = 6–8 rats for each group. ※P < 0.05 vs. the sham group; #P < 0.05 vs. the CA group.
FIGURE 6 | Effect of sevoflurane post-conditioning on ROS generation, the degree of MPTP opening and MMP in the hippocampus at 24 and 72h after
reperfusion. (A) mROS production was measured by using DCFH -DA at 24 and 72 h after reperfusion. (B,C) Mitochondrial integrity was measured in hippocampal
cells following treatment with or without sevoflurane. The results are expressed as percentage of the sham group and presented as mean ± S.D. n = 6–8 rats for each
group. ※P < 0.05 vs. the sham group; #P < 0.05 vs. the CA group.
that sevoflurane was able to inhibit the generation of mROS in
hypoxic hippocampal neurons.
To determine mitochondrial integrity, we detected the
opening of mitochondrial permeability transition pore (MPTP),
as well as mitochondrial membrane potential (MMP). Opening
of the MPTP is important for mitochondrial events leading to
programmed cell death. As compared to the sham group, the
activity of MPTP in hippocampal neurons significantly increased
in the CA group (356.8% at 1 h and 276.1% at 3 days, P < 0.05)
and sevoflurane post-conditioning could decline the activity of
MPTP in hippocampal neurons (214.5% at 1 day and 189.2 at 3
days, P < 0.05, Figure 6B).
The loss of MMP is the result of the opening of permeability
transition pores. As shown in Figure 6C, global ischemic injury
induced a significant loss of MMP in the CA group in
mitochondria hippocampal tissue (80.25% at 1 h and 82.37% at
3 days, P < 0.05). However, sevoflurane post-treatment rescued
markedly the loss of MMP in the therapy group (90.63% at 1 h
and 87.25% at 3 days, P < 0.05).
Sevoflurane-Delayed Post-conditioning
Was Mediated by the PI3K/Akt Survival
Pathway
Similarly as aforementioned, sevoflurane significantly increased
p-Akt (Ser473), mitochondrial biogenesis-related proteins such
as PGC-1α, NRF-1 and TFAM, and mitochondria-specific
antioxidants including HSP60, Trx2, and Prx2 in hippocampal
tissue, compared with the sham and control groups at 24 h
after reperfusion. Administration of PI3K inhibitor wortmannin
decreased the elevation of p-Akt level, mitochondrial biogenesis-
related proteins and mitochondria-specific antioxidants induced
by sevoflurane post-conditioning (P < 0.05, Figures 7A–D).
However, total Akt expression was not obviously changed in
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FIGURE 7 | Sevoflurane enhanced neuron resistance to global cerebral injury by the PI3K/AKT signaling pathway. (A,C) Western blots analysis for p-Akt,
mitochondrial biogenesis related proteins, and mitochondria-specific antioxidant enzymes at 24 h after reperfusion. (B,D) Quantitative analysis for the level of p-Akt,
mitochondrial biogenesis-related proteins and mitochondria-specific antioxidant enzymes. (E–G) Effect of wortmannin on sevoflurane post-conditioning-inhibited
mROS generation, loss of MMP and opening of MPTP. Data are expressed as mean ± S.D. n = 6–8 rats for each group. ※P < 0.05 vs. SE+W group; #P < 0.05 vs.
the CA group.
all groups (P > 0.05). There was no significant difference in
protein levels between the control group and the wortmannin
alone (CA+W) group (P > 0.05).
Sevoflurane post-conditioning also ameliorated
mitochondrial ROS generation and restored the mitochondrial
integrity. Nevertheless, wortmannin treatment eliminated
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the beneficial biochemical processes of sevoflurane, shown as
increased mitochondrial ROS generation, and loss of MMP
and opening of MPTP at 24 h of reperfusion (P < 0.05,
Figures 7E–G). There was no significant difference in all the
parameters between the control group and the CA+W group (P
> 0.05).
DISCUSSION
Although a continually improved outcome after global brain
ischemia induced by CA or cardiopulmonary bypass surgery
has been achieved in patients, there has been no revolutionary
breakthrough. Therefore, understanding the mechanisms
responsible for brain injury due to global ischemia and finding
new neuroprotective strategies are critical and will be useful in
clinical settings (Yannopoulos et al., 2011).
Growing evidence has shown that treatment with sevoflurane,
a volatile anesthetic agent, before or after ischemia can improve
neuronal recovery after the insult (Ye et al., 2012a,b,c, 2015).
Hence, sevoflurane may be ideal chemical preconditioning
or post-conditioning agents since they are safe and broadly
used in clinical practice. Until now, the pro-apoptotic pathway
has been the main pathogenesis in neuronal cell death
induced by cerebral ischemic insult. In the current paper,
we demonstrated that sevoflurane post-conditioning efficiently
increased post-ischemic survival rates. Furthermore, sevoflurane
post-conditioning significantly attenuated the activation of
caspase-3 and -9 to reduce post-ischemic neuronal apoptosis.
Therefore, our data suggest that sevoflurane post-conditioning
is remarkably effective in preventing neuronal apoptosis in the
hippocampus in a model of CA-induced global cerebral ischemia.
Accumulating evidence has strongly implicated that
mitochondria may be involved in causing ischemia-related
cell death (Doll et al., 2015; Lu et al., 2015; Jin et al., 2016).
Normal mitochondrial function plays an essential role in
promoting neuronal survival after ischemic reperfusion injury.
Previous studies have found that improved mitochondrial
biogenesis can reduce neuronal damage during cerebral ischemia
through stimulating the renewal of mitochondrial function
(Liu et al., 2014; Pan et al., 2014). Although sevoflurane post-
conditioning has the ability to prevent cerebral ischemia-induced
apoptosis, its effect on mitochondrial biogenesis and function
has not been well-studied. Mitochondrial DNA (mtDNA)
replication is necessary for mitochondrial biogenesis and is a
typical marker for this process. Moreover, mtDNA quantity
is an indicator of mitochondria content. We measured the
amount of mtDNA using real-time PCR to dissect the effect of
sevoflurane on mitochondrial biogenesis. We showed that in
contrast to ischemic stimulation, sevoflurane post-conditioning
significantly increased the amount of mtDNA. Additionally,
mitochondrial biogenesis is a highly regulated process that
requires the participation of both the nuclear and mitochondrial
genomes. To investigate the molecular mechanisms that might
be responsible for regulating mitochondrial biogenesis after
sevoflurane post-conditioning, we examined three transcription
factors considered essential for mitochondrial gene expression.
PGC-1α is a co-transcriptional regulation factor that induces
mitochondrial biogenesis by activating different transcription
factors, including nuclear respiratory factors 1 and 2 proteins
(NRF-1 and NRF-2; Kleiner et al., 2009; Sharma et al., 2015).
Furthermore, PCG-1α indirectly induces mtDNA replication
and transcription by increasing the expression of mtDNA
regulatory genes, including mitochondrial transcriptional factor
A (TFAM; Wu et al., 1999; Kleiner et al., 2009). It is known that
the transcriptional activity of NRF-1 is enhanced by PCG-1α in
mitochondrial biogenesis (Escrivá et al., 1999; Scarpulla, 2002;
Ping et al., 2015), and the expression of TFAM is, at least partially,
under the control of NRF-1 (Escrivá et al., 1999; Biala et al.,
2010). Up-regulation of PCG-1α coordinates gene activation
and facilitates mitochondrial biogenesis. Numerous studies
have demonstrated that ischemic or hypoxic injury increases
mitochondrial biogenesis (Pan et al., 2014; Wang et al., 2014; Xie
et al., 2014). Thus, to further support sevoflurane’s protective
effect on mitochondrial biogenesis, the gene and protein levels
of three critical genes for the transcriptional regulation of
mitochondrial biogenesis, PGC-1α, NRF-1, and TFAM, were
investigated. Compared with the global cerebral ischemia group,
the sevoflurane post-conditioning group had much higher gene
and protein expression levels of PGC-1α, NRF-1, and TFAM in
the hippocampus after reperfusion. Therefore, in this current
study, comparable to the increase in mtDNA, an increase in the
expression of three mitochondrial biogenesis-related proteins
was found. Actually, mitochondrial biogenesis can be induced by
ischemic or hypoxic damage, and this enhanced mitochondrial
biogenesis may increase the abundance of mtDNAs and
maintain their aerobic set-point in case of declining function.
In brief, our findings suggest that sevoflurane can effectively
improve mitochondrial biogenesis through facilitating mtDNA
amplification and elevating PGC-1α, NRF-1, and TFAM gene
and protein expression.
Recently, substantial evidence has indicated that the Trx
and Prx redox system is associated with neuronal damage and
neuroprotective effects via the regulation of oxidative stress in
brain ischemia (Hwang et al., 2010; Lee et al., 2015). To gain
additional evidence for sevoflurane post-conditioning-induced
neuroprotection against cerebral ischemia, the expression level
of several proteins normally enriched in mitochondria was
investigated. Peroxiredoxin 3 (Prx3) is exclusively found in
mitochondria and plays a role in the antioxidant defense system
and homeostasis within mitochondria (Hwang et al., 2010;
Du et al., 2014). Thioredoxin 2 (Trx2) is expressed with a
mitochondrial leading sequence and transported specifically into
mitochondria, playing an essential role in cell survival and
mitochondria-mediated apoptosis (Ma et al., 2013; Lee et al.,
2015). Among the subtypes of Trx and Prx, Prx3 and Trx2 are
exclusively expressed in the mitochondrial compartment, and
are involved in the control of the antioxidant defense system,
cell survival, and apoptosis. A recent paper pointed out that
treatment with Prx3 and Trx2 in ischemic brains showed a potent
neuroprotective effect against ischemic damage by reducing lipid
peroxidation and mitochondria-mediated apoptosis (Hwang
et al., 2010). Additionally, the mitochondrial chaperonins
composed of heat shock protein 60 (HSP60) are the major
sites of protein folding in mitochondria. HSP60 is an abundant
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protein located primarily in mitochondria, with only 15–20%
normally found in the cytosol (Sun et al., 2014). In addition, the
upregulation of HSP60 is indicative of mitochondrial biogenesis
(Li et al., 2014). Our findings showed that Prx3, Trx2, and HSP60
in the mitochondria of the sevoflurane group was much higher
than those in the CA group, suggesting that amelioration of
cerebral ischemic injury by sevoflurane may be attributed to its
up-regulation of mitochondrial antioxidases.
Although we have shown that sevoflurane post-conditioning
triggered significant protection against CA-induced global
cerebral ischemia by preserving mitochondrial biogenesis and
promoting mitochondrial antioxidant enzymes, the underlying
mechanism for sevoflurane’s neuroprotection effect remains
to be elucidated. On the other hand, mitochondria are also
regarded as the critical regulators of cell death and major
cellular sources of ROS, which causes damage to mtDNA
in neuronal cells (Watabe et al., 1997; Tanaka et al., 2002).
Surplus amount of ROS generation may result in the loss of
mitochondrial membranes potential (MMP) and the opening
of mitochondrial permeability transition pore (MPTP) and
cause mitochondrial dysfunction, which in turn modulates pro-
apoptotic protein activation (Gupta and Knowlton, 2002; Yin
et al., 2008). Therefore, we determined the effects of sevoflurane
post-conditioning on mROS production, MMP and the opening
of MPTP. Sevoflurane caused a decrease in mROS generation,
MPTP opening, as well as in salvage of MMP indicating that
sevoflurane could retain mitochondrial integrity post-ischemia.
In fact, the Trx2 and Prx3 redox system and HSP60 are
important in mitochondrial function by reducing oxidative stress
via regulating mROS levels.
Consistent with other studies, we have also demonstrated
that activation of the PI3K/Akt pathway mediated salvage
of neurons against infarction during post-conditioning by
the volatile anesthetic agent sevoflurane. It is interesting
to note that wortmannin, a PI3K inhibitor, abolished the
neuroprotective effect of sevoflurane post-conditioning by
significantly decreasing the protein levels of p-Akt (Ser473),
mitochondrial biogenesis-related proteins (PGC-1α, NRF-1, and
TFAM), and mitochondria-specific antioxidant enzymes, as well
as increasing mROS production and aggravating mitochondrial
integrity. These results suggested that sevoflurane might elicit the
protective role in global cerebral ischemic injury by regulating
the PI3K/Akt survival pathway. Actually, PI3K/Akt signaling was
found to be reversely associated with mitochondria oxidative
stress and activation of PI3K/AKT signaling reduced ROS
production (Dai et al., 2013; Zhu et al., 2015). Furthermore,
phosphorylated Akt (p-Akt) not only acts to inhibit pro-
apoptotic factors and stimulate anti-apoptotic factors, but also
inactivates mitochondria-based oxidative stress (Wang et al.,
2015; Xu et al., 2015). Hence, our findings support the hypothesis
that sevoflurane ameliorated mROS formation post-ischemia
by up-regulation of Trx2, Prx3, and HSP60 expression and
interrupted the subsequent cascade reaction, which eventually
resulted in improving mitochondrial biogenesis and integrity,
possibly via the activation of the PI3K/Akt survival pathway.
Nevertheless, we have only shown that the PI3K/Akt
survival pathway mediated acute (24 h) post-conditioning
neuroprotection induced by sevoflurane. The long-term effect
(up to 28 days post cerebral ischemia) of sevoflurane post-
conditioning is still unclear, which may be a major limitation of
this present study.
In conclusion, administration of sevoflurane after reperfusion
was able to significantly induce the gene and protein levels of
mitochondrial pro-survival proteins, including PGC-1α, NRF-
1, and TFAM, up-regulate mitochondria-specific antioxidant
enzyme expression, and restore mitochondrial integrity. In
parallel, the level of cleaved caspase-3 and -9, two proteins
involved in apoptotic cell death, and the number of damaged
neurons in hippocampus sections were reduced in the presence of
sevoflurane. Furthermore, the protective role of sevoflurane post-
conditioning-triggered brain protection was mediated through
PI3K/AKT signaling. Accordingly, this research may support a
promising therapeutic avenue for the treatment of global cerebral
ischemic injury during the preoperative period. Future studies
will further investigate the in vitro mechanisms of sevoflurane
post-conditioning.
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